Interpretation of idarucizumab clinical trial data based on spontaneous reports of dabigatran adverse effects in the French pharmacovigilance database.
-
アブストラクト ジャーナル名 Thrombosis research 投稿日 2016/9/1 投稿者 Trinh-Duc, Albert; Lillo-Le Louet, Agnes; Tellier, Eric; Viard, Thibault; Le Gal, Gregoire; Smadja, David M 組織名 St Esprit Hospital, Emergency Department, Agen, France.;AP-HP, European Hospital Georges Pompidou, Pharmacovigilance Department, Paris,;France.;Universite de Brest, EA3878 Brest, France; University of Ottawa, Department of;Medicine, Ottawa, Canada.;Paris Descartes University, Sorbonne Paris Cite, Paris, France; Inserm UMR-S1140,;Paris, France; AP-HP, European Hospital Georges Pompidou, Hematology Department,;Paris, France. Electronic address: david.smadja@aphp.fr. Pubmed リンク https://www.ncbi.nlm.nih.gov/pubmed/27579488/ -
お問合わせ
検索
メルマガ登録
